MedPath

Opceden� Bilberry Eyebright PLUS Capsule

Registration Number: MAL12055078TC

Approved
Approval ID

23cb5f8f437eb203

Registration Number

MAL12055078TC

Registration Date

Jul 4, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types7 types
Last UpdatedJul 4, 2025

PACKAGING INFORMATION (7)

10 CapsulesAvailable
Package Size: 10 Capsules
Status: NPRA Approved
30 CapsulesAvailable
Package Size: 30 Capsules
Status: NPRA Approved
60 CapsulesAvailable
Package Size: 60 Capsules
Status: NPRA Approved
90 CapsulesAvailable
Package Size: 90 Capsules
Status: NPRA Approved
120 CapsulesAvailable
Package Size: 120 Capsules
Status: NPRA Approved
150 CapsulesAvailable
Package Size: 150 Capsules
Status: NPRA Approved
300 CapsulesAvailable
Package Size: 300 Capsules
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (5)

Calendula officinalisActive
Lycium barbarumActive
Monograph: lycium barbarum
Euphrasia officinalisActive
Monograph: euphrasia officinalis
Vaccinium myrtillusActive
Monograph: Bilberry
Vitis ViniferaActive

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Opceden� Bilberry Eyebright PLUS Capsule - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform